Lilly's cancer therapy Lartruvo fails study, shares drop

Deutschland Nachrichten Nachrichten

Lilly's cancer therapy Lartruvo fails study, shares drop
Deutschland Neuesten Nachrichten,Deutschland Schlagzeilen
  • 📰 Reuters
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 97%

Eli Lilly and Co said on Friday its cancer treatment Lartruvo, approved on an ac...

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

Reuters /  🏆 2. in US

Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Lilly cancer drug fails key trial, will no longer be prescribedLilly cancer drug fails key trial, will no longer be prescribedEli Lilly and Co said on Friday that its cancer treatment Lartruvo, which had wo...
Weiterlesen »

Lilly eyes more cancer deals, but wary of CAR-T, gene therapyLilly eyes more cancer deals, but wary of CAR-T, gene therapyEli Lilly and Co remains in the hunt for cancer drugs even after announcing an $...
Weiterlesen »

Eli Lilly shares slide premarket on news of failed trial for sarcoma treatmentEli Lilly shares slide premarket on news of failed trial for sarcoma treatment
Weiterlesen »

Stocks making the biggest moves premarket: Tesla, CVS Health, Eli Lilly, Netflix & moreStocks making the biggest moves premarket: Tesla, CVS Health, Eli Lilly, Netflix & moreSome of the names on the move ahead of the open.
Weiterlesen »

Stocks making the biggest moves midday: Netflix, Boeing, Tesla, Eli Lilly & moreStocks making the biggest moves midday: Netflix, Boeing, Tesla, Eli Lilly & moreCheck out the companies making headlines midday Friday.
Weiterlesen »

Eli Lilly’s Sarcoma Drug Combo Proves Ineffective in TrialsEli Lilly’s Sarcoma Drug Combo Proves Ineffective in TrialsEli Lilly said it would stop promoting Lartruvo, a relatively new cancer drug, after a study found it didn’t significantly prolong the lives of patients when used in combination with an older drug.
Weiterlesen »

House Democrats launch drug-pricing probe into a dozen major health-care companiesHouse Democrats launch drug-pricing probe into a dozen major health-care companiesAbbVie, Amgen, AstraZeneca, Celgene, Eli Lilly, Johnson & Johnson, Mallinckrodt, Novartis, Novo Nordisk, Pfizer, Sanofi and Teva Pharmaceuticals received letters seeking detailed information and documents about the companies' pricing practices.
Weiterlesen »



Render Time: 2025-04-28 06:23:49